Sun Pharma Advanced Research Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 59.31 | -100% | -29.86 | -100% |
| P/S |
|
161.88 | 8.62 | 1778.63% |
|
|
| P/BV |
|
97.25 | 6.53 | 1389.16% |
|
|
| P/FCF |
|
-14.41 | 0.6184 | -2430.55% |
|
|
| Ev/Ebitda |
|
-30.18 | 141.72 | -121.3% |
|
|
| Ev/S |
|
160.63 | 8.63 | 1761.01% |
|
|
| Ev/FCF |
|
-27.9 | 7.72 | -461.42% |
|
|
| E/P |
|
-0.0618 | 0.1367 | -145.19% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-532.23 | 0.3647 | -146026.33% | -241.32 | +120.55% |
| ROE |
|
-307.92 | 7.22 | -4363.62% |
|
|
| ROA |
|
-75.18 | 6.7 | -1222.68% |
|
|
| ROIC |
|
0 | 15.91 | -100% |
|
|
| ROS |
|
-512.52 | -4.66 | 10887.02% |
|
|
| ROCE |
|
-329.71 | 11.71 | -2915.75% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1521 | 123.39 | -100.12% | -0.5379 | -71.73% |
| Nеt Debt/Ebitda |
|
0.2342 | 121.88 | -99.81% |
|
|
| Debt/Ratio |
|
0.1187 | 0.1698 | -30.07% |
|
|
| Debt/Equity |
|
0.57 | 3.45 | -83.45% |
|
|
| Debt/Net Income |
|
-0.1579 | 3.06 | -105.16% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 9.59 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7073 | -100% | ||
| DSI |
|
0 | 0.8351 | -100% |
|
|
| Average dividend growth |
|
0 | -2.19 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 14.83 | -100% |
|
|
| Average percentage for payments |
|
0 | 24.67 | -100% |
|
|
| Difference from average difference in sector |
|
-9.59 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-1.65 | 695.45 | -100.24% | ||
| Growth impulse Ebitda in 5 years |
|
30.96 | 617.6 | -94.99% | ||
| Growth impulse Net Income in 5 years |
|
23.95 | 759.48 | -96.85% | ||
| Growth impulse FCF in 5 years |
|
64.22 | 1011.9 | -93.65% | ||
| Growth impulse EPS in 5 years |
|
2.32 | 220.4 | -98.95% |
IP Score
3.08/10
